Zhao X, Ma W, Li X, Li H, Li J, Li H
J Cancer. 2021; 12(5):1295-1306.
PMID: 33531975
PMC: 7847635.
DOI: 10.7150/jca.52171.
Ganesan T, Sinniah A, Ibrahim Z, Chik Z, Alshawsh M
Molecules. 2020; 25(16).
PMID: 32823805
PMC: 7465196.
DOI: 10.3390/molecules25163700.
Moraes L, Ampomah P, Lim L
Cell Adh Migr. 2018; 12(5):417-423.
PMID: 30122097
PMC: 6363057.
DOI: 10.1080/19336918.2018.1486143.
Xie H, Xue Y, Liu P, Zhang P, Tian S, Yang Z
World J Gastroenterol. 2018; 24(3):371-378.
PMID: 29391759
PMC: 5776398.
DOI: 10.3748/wjg.v24.i3.371.
Kim S, Faix P, Schnitzer J
J Control Release. 2017; 267:15-30.
PMID: 28917530
PMC: 8756776.
DOI: 10.1016/j.jconrel.2017.09.016.
Regulation of inflammation by members of the formyl-peptide receptor family.
Chen K, Bao Z, Gong W, Tang P, Yoshimura T, Wang J
J Autoimmun. 2017; 85:64-77.
PMID: 28689639
PMC: 5705339.
DOI: 10.1016/j.jaut.2017.06.012.
Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer.
Satoh M, Takano S, Sogawa K, Noda K, Yoshitomi H, Ishibashi M
Cancer Sci. 2017; 108(4):795-803.
PMID: 28161904
PMC: 5406537.
DOI: 10.1111/cas.13181.
Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer.
Hatoum D, Yagoub D, Ahadi A, Nassif N, McGowan E
PLoS One. 2017; 12(1):e0169925.
PMID: 28068434
PMC: 5222396.
DOI: 10.1371/journal.pone.0169925.
Changes in the in vitro activity of platinum drugs when administered in two aliquots.
Al-Eisawi Z, Beale P, Chan C, Yu J, Proschogo N, Molloy M
BMC Cancer. 2016; 16:688.
PMID: 27566066
PMC: 5002105.
DOI: 10.1186/s12885-016-2731-1.
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.
Bhardwaj A, Ganesan N, Tachibana K, Rajapakshe K, Albarracin C, Gunaratne P
PLoS One. 2015; 10(5):e0127678.
PMID: 26000884
PMC: 4441370.
DOI: 10.1371/journal.pone.0127678.
Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.
Anbalagan D, Yap G, Yuan Y, Pandey V, Lau W, Arora S
PLoS One. 2014; 9(12):e114507.
PMID: 25536365
PMC: 4275173.
DOI: 10.1371/journal.pone.0114507.
Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo T, Cunha B, Raposo L, Maniglia J, Cury P, Lisoni F
PLoS One. 2014; 9(12):e111317.
PMID: 25490767
PMC: 4260827.
DOI: 10.1371/journal.pone.0111317.
Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.
Sheu M, Li C, Lin C, Lee S, Lin L, Chen T
Tumour Biol. 2014; 35(8):7755-63.
PMID: 24810927
DOI: 10.1007/s13277-014-2032-8.
Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer.
Queiroz C, Nakata C, Solito E, Damazo A
Infect Agent Cancer. 2014; 9:13.
PMID: 24782913
PMC: 4003510.
DOI: 10.1186/1750-9378-9-13.
Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs.
Calmon M, Mota M, Babeto E, Candido N, Girol A, Mendiburu C
PLoS One. 2013; 8(1):e53260.
PMID: 23341933
PMC: 3544802.
DOI: 10.1371/journal.pone.0053260.
Clinical significance of annexin A1 expression in breast cancer.
Yom C, Han W, Kim S, Kim H, Shin H, Chang J
J Breast Cancer. 2012; 14(4):262-8.
PMID: 22323911
PMC: 3268921.
DOI: 10.4048/jbc.2011.14.4.262.
Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer.
Wu Y, Elshimali Y, Sarkissyan M, Mohamed H, Clayton S, Vadgama J
Am J Cancer Res. 2011; 2(1):104-15.
PMID: 22206049
PMC: 3236574.
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.
Damazo A, Sampaio A, Nakata C, Flower R, Perretti M, Oliani S
BMC Immunol. 2011; 12:59.
PMID: 22011168
PMC: 3212807.
DOI: 10.1186/1471-2172-12-59.
Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2.
Suo A, Zhang M, Yao Y, Zhang L, Huang C, Nan K
Med Oncol. 2011; 29(3):1827-36.
PMID: 21735146
DOI: 10.1007/s12032-011-0013-y.
2D-DIGE proteomic analysis of changes in estrogen/progesterone-induced rat breast hyperplasia upon treatment with the Mongolian remedy RuXian-I.
Wang Z, E D, Batu D, Saixi Y, Zhang B, Ren L
Molecules. 2011; 16(4):3048-65.
PMID: 21478820
PMC: 6260641.
DOI: 10.3390/molecules16043048.